SCHEMBL924324

SCHEMBL924324

Cc1n[nH]c(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9126671 0.77 — —
SCHEMBL21737680 0.74 — —
SCHEMBL20844121 0.72 — —
SCHEMBL27845754 0.72 — —
SCHEMBL20844143 0.72 — —
SCHEMBL10962770 0.72 — —
SCHEMBL17522837 0.72 — —
SCHEMBL12732019 0.69 DYRK1A (0.33) —
SCHEMBL20844107 0.69 — —
SCHEMBL3465033 0.69 DYRK1A (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103553-A1 NEW PROCESS FOR THE SYNTHESIS OF 5-FLUORO-3- (DIFUOROMETHYL) -5-FLUORO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE FREE ACID THEREOF Fujian Yongjing Technology Co., Ltd (CN) 2022-12-21 — — EP claimed
US-20220372000-A1 New Process for the Synthesis of 5-Fluoro-3-(Difuoromethyl)-5-Fluoro-1-Methyl-1H-Pyrazole-4-Carboxylic Acid Derivatives and the Free Acid Thereof Fujian Yongjing Technology Co.,Ltd (CN) 2022-11-24 — — US claimed
CN-114450269-A Novel method for synthesizing 5-fluoro-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazole-4-carboxylic acid derivative and free acid thereof 福建永晶科技股份有限公司 2022-05-06 — — CN claimed
CN-120081788-A Pyrazole amide compound containing 2- (4-bromo-2- (trifluoromethyl) phenoxy) phenyl fragment and application thereof 安徽理工大学 2025-06-03 — — CN disclosed
CN-120091815-A T-type voltage-gated calcium channel enhancer 广泛研究所股份有限公司 2025-06-03 — — CN disclosed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 — — US disclosed
US-12180226-B2 Spirotricycle RIPK1 inhibitors and methods of uses thereof MERCK SHARP & DOHME LLC (US) 2024-12-31 — — US disclosed
CN-116535357-B Arylamino benzamide derivative containing substituted pyrazole structure, preparation method and application 西北农林科技大学 2024-10-11 — — CN disclosed
EP-4423096-A1 SPIROTRICYCLE RIPK1 INHIBITORS AND METHODS OF USES THEREOF Merck Sharp & Dohme LLC (US) 2024-09-04 — — EP disclosed
CN-118488957-A Spirotricyclic RIPK1 inhibitors and methods of use thereof 默沙东有限责任公司 2024-08-13 — — CN disclosed
CN-117534616-B Synthesis method of 3-difluoromethyl-1, 5-disubstituted pyrazole compound 西北师范大学 2024-07-30 — — CN disclosed
WO-2012163905-A1 METHOD FOR PREPARING A FLUORINATED ORGANIC COMPOUND RHODIA OPERATIONS (FR) 2012-12-06 — — WO disclosed
EP-2215096-B1 COPPER-OXYGEN ADDUCT COMPLEXES UNIV GIESSEN JUSTUS LIEBIG (DE) 2012-09-19 — — EP disclosed
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2012-01-19 — — US disclosed
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2012-01-19 — — US disclosed
US-7875647-B2 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders GREEN CROSS CORPORATION (KR) 2011-01-25 — — US disclosed
EP-2097410-A1 HETEROARYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS Green Cross Corporation (KR) 2009-09-09 — — EP disclosed
WO-2009052809-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) 2009-04-30 — — WO disclosed
US-20080081812-A1 Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists GREEN CROSS CORPORATION (KR) 2008-04-03 — — US disclosed
WO-2008039023-A1 HETEROARYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS GREEN CROSS CORPORATION (KR) 2008-04-03 — — WO disclosed
Send feedback